Patents by Inventor Omer H. Yilmaz

Omer H. Yilmaz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8383404
    Abstract: The present invention relates to methods of identifying, collecting and isolating hematopoietic stem cells (HSCs) and compositions of purified HSCs. Specifically, the present invention provides methods of isolating and purifying CD150+ HSCs, CD48? HSCs, and CD244? HSCs. The present invention also relates to purified cell samples with enriched CD150+ HSCs, CD48? HSCs, and CD244? HSCs populations, as well as methods of treating subjects with such compositions.
    Type: Grant
    Filed: January 24, 2011
    Date of Patent: February 26, 2013
    Assignee: The Regents of the University of Michigan
    Inventors: Omer H. Yilmaz, Mark J. Kiel, Sean Morrison, Toshihide Iwashita
  • Publication number: 20110143430
    Abstract: The present invention relates to methods of identifying, collecting and isolating hematopoietic stem cells (HSCs) and compositions of purified HSCs. Specifically, the present invention provides methods of isolating and purifying CD150+ HSCs, CD48? HSCs, and CD244? HSCs. The present invention also relates to purified cell samples with enriched CD150+ HSCs, CD48? HSCs, and CD244? HSCs populations, as well as methods of treating subjects with such compositions.
    Type: Application
    Filed: January 24, 2011
    Publication date: June 16, 2011
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Omer H. Yilmaz, Mark J. Kiel, Sean Morrison, Toshihide Iwashita
  • Patent number: 7919316
    Abstract: The present invention relates to methods of identifying, collecting and isolating hematopoietic stem cells (HSCs) and compositions of purified HSCs. Specifically, the present invention provides methods of isolating and purifying CD150+ HSCs, CD48? HSCs, and CD244? HSCs. The present invention also relates to purified cell samples with enriched CD150+ HSCs, CD48? HSCs, and CD244? HSCs populations, as well as methods of treating subjects with such compositions.
    Type: Grant
    Filed: February 19, 2009
    Date of Patent: April 5, 2011
    Assignee: The Regents of the University of Michigan
    Inventors: Omer H. Yilmaz, Mark J. Kiel, Sean Morrison, Toshihide Iwashita
  • Publication number: 20090227019
    Abstract: The present invention relates to methods of identifying, collecting and isolating hematopoietic stem cells (HSCs) and compositions of purified HSCs. Specifically, the present invention provides methods of isolating and purifying CD150+ HSCs, CD48? HSCs, and CD244? HSCs. The present invention also relates to purified cell samples with enriched CD150+ HSCs, CD48? HSCs, and CD244? HSCs populations, as well as methods of treating subjects with such compositions.
    Type: Application
    Filed: February 19, 2009
    Publication date: September 10, 2009
    Applicant: The Regents of the University of Michigan
    Inventors: Omer H. Yilmaz, Mark J. Kiel, Sean Morrison, Toshihide Iwashita
  • Publication number: 20090143418
    Abstract: The present invention relates to compositions and methods for the preventing, treating, and researching discoloration (e.g., hair graying, hair whitening, undesired change in hair color). In particular, the present invention provides compositions and methods for treating, preventing and researching hair discoloration through inhibition of mTOR function (e.g., mTOR activity, mTOR expression). In addition, the present invention provides methods and compositions that utilize mTOR inhibiting agents in the preventing, treating, and researching hair discoloration.
    Type: Application
    Filed: October 31, 2008
    Publication date: June 4, 2009
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Jesse R. Dixon, Omer H. Yilmaz, Sean J. Morrison
  • Patent number: 7510877
    Abstract: The present invention relates to methods of identifying, collecting and isolating hematopoietic stem cells (HSCs) and compositions of purified HSCs. Specifically, the present invention provides methods of isolating and purifying CD150+ HSCs, CD48? HSCs, and CD244? HSCs. The present invention also relates to purified cell samples with enriched CD150+ HSCs, CD48? HSCs, and CD244? HSCs populations, as well as methods of treating subjects with such compositions.
    Type: Grant
    Filed: September 27, 2004
    Date of Patent: March 31, 2009
    Assignee: The Regents of the University of Michigan
    Inventors: Omer H. Yilmaz, Mark J. Kiel, Sean Morrison, Toshihide Iwashita